TAM
ALNY icon

Tocqueville Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,000
Closed -$437K 704
2020
Q3
$437K Hold
3,000
0.01% 512
2020
Q2
$444K Hold
3,000
0.01% 505
2020
Q1
$327K Hold
3,000
0.01% 526
2019
Q4
$346K Buy
+3,000
New +$346K 0.01% 618
2019
Q2
Sell
-7,700
Closed -$720K 774
2019
Q1
$720K Buy
+7,700
New +$720K 0.01% 525
2018
Q4
Sell
-42,481
Closed -$3.72M 747
2018
Q3
$3.72M Sell
42,481
-12,235
-22% -$1.07M 0.05% 337
2018
Q2
$5.39M Sell
54,716
-21,745
-28% -$2.14M 0.07% 284
2018
Q1
$9.11M Sell
76,461
-77,575
-50% -$9.24M 0.12% 193
2017
Q4
$19.6M Buy
154,036
+133,261
+641% +$16.9M 0.22% 122
2017
Q3
$2.44M Buy
20,775
+4,200
+25% +$493K 0.03% 421
2017
Q2
$1.32M Buy
16,575
+2,400
+17% +$191K 0.02% 467
2017
Q1
$726K Sell
14,175
-2,830
-17% -$145K 0.01% 531
2016
Q4
$637K Sell
17,005
-93,440
-85% -$3.5M 0.01% 558
2016
Q3
$7.49M Sell
110,445
-3,525
-3% -$239K 0.09% 233
2016
Q2
$6.32M Sell
113,970
-525
-0.5% -$29.1K 0.08% 257
2016
Q1
$7.19M Buy
114,495
+4,725
+4% +$297K 0.1% 226
2015
Q4
$10.3M Sell
109,770
-575
-0.5% -$54.1K 0.14% 174
2015
Q3
$8.87M Buy
110,345
+24,810
+29% +$1.99M 0.12% 210
2015
Q2
$10.3M Buy
85,535
+1,950
+2% +$234K 0.12% 205
2015
Q1
$8.73M Buy
83,585
+55,335
+196% +$5.78M 0.1% 226
2014
Q4
$2.74M Sell
28,250
-2,000
-7% -$194K 0.03% 426
2014
Q3
$2.36M Sell
30,250
-550
-2% -$43K 0.03% 406
2014
Q2
$1.95M Buy
30,800
+8,300
+37% +$524K 0.02% 475
2014
Q1
$1.51M Sell
22,500
-5,000
-18% -$336K 0.02% 401
2013
Q4
$1.77M Hold
27,500
0.02% 394
2013
Q3
$1.76M Sell
27,500
-1,200
-4% -$76.8K 0.02% 448
2013
Q2
$890K Buy
+28,700
New +$890K 0.01% 523